Site Search

Results from the COMBACTE-CARE project show that – if approved – a new combination of drugs could help in the fight against some of the most dangerous drug-resistant bacteria.

iCARE4CVD has delivered an innovative new tool to harmonise data in the cardiovascular disease field, a key step towards advancing more personalised care.

Data gathered during IMI project DIRECT helped scientists to pinpoint genetic variants associated with a good response to diabetes drugs called GLP-1 agonists.

Early feasibility studies can accelerate innovation in medical devices, but there is no clear roadmap on how to implement or assess them in Europe. HEU-EFS developed a framework to...

The joint undertakings are about creating public-private partnerships (PPPs) – and IHI is no exception. In an interview, the European Commission’s Irene Norstedt, chair of the...

The papers in Frontiers in Neurology demonstrate how public-private collaborative research through IMI and now IHI is making a difference in the Alzheimer’s disease field.